<DOC>
	<DOC>NCT02796105</DOC>
	<brief_summary>Evaluation of efficacy and safety of medroxiprogesterone acetate (Progevera 10 mg®) versus GnRh antagonist (Orgalutran®) in ovarian stimulation cycles of oocyte donors</brief_summary>
	<brief_title>Progevera 10 mg® Versus Orgalutran® in Ovarian Stimulation Cycles of Oocyte Donors</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Ganirelix</mesh_term>
	<criteria>Oocyte donors included in the oocyte donation program of Clinica EUGIN. 1st oocyte donation cycle at Clínica EUGIN. Polycistic Ovarian syndrome (PCOs). Estradiol levels on day 2 of menstrual cycle &gt;70 pg/ml. Hormone treatments up to 3 months before the oocyte donation cycle. Medical contraindication to the treatments used in the study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>